Continuous glucose monitoring in cystic fibrosis – A practical guide

Christine L. Chan; Katie Larson Ode; Andrea Granados; Amir Moheet; Antoinette Moran; Shihab Hameed

doi:10.1016/j.jcf.2019.08.025

Back

Continuous glucose monitoring in cystic fibrosis – A practical guide

Journal article

Open access

Peer reviewed

Continuous glucose monitoring in cystic fibrosis – A practical guide

Christine L. Chan, Katie Larson Ode, Andrea Granados, Amir Moheet, Antoinette Moran and Shihab Hameed

Journal of cystic fibrosis, Vol.18, pp.S25-S31

10/2019

DOI: 10.1016/j.jcf.2019.08.025

PMID: 31679725

Files and links (1)

url

https://doi.org/10.1016/j.jcf.2019.08.025View

Published (Version of record) Open Access

Abstract

Our ability to monitor blood glucose levels has become increasingly accurate over the last few decades. Continuous glucose monitoring (CGM) technology now allows providers and patients the ability to monitor glucose levels retrospectively as well as in real-time for diabetes management. CGM also provides the ability to study glucose patterns and trends for insight into the pathophysiology and natural history of disease. CGM captures a more complete picture of glucose profiles than traditional measures of glycemia such as the hemoglobin A1c or self-monitoring of blood glucose levels. This article provides a review of the history of glucose monitoring, a review of the literature pertaining to CGM with a focus on studies in patients with cystic fibrosis, and discusses practical uses of CGM technology and its application for the evaluation and management of cystic fibrosis related diabetes. •CGM systems are useful adjunctive tools for the screening and monitoring of CFRD.•CGM abnormalities may be present even in individuals with normal glucose tolerance.•Abnormalities on CGM correlate with adverse outcomes including reduced FEV1 and BMI.•No official CGM guidelines have been published to guide CFRD management.

Artificial pancreas

Continuous glucose monitoring

Cystic fibrosis related diabetes

Details

Title: Subtitle: Continuous glucose monitoring in cystic fibrosis – A practical guide
Creators: Christine L. Chan - Children's Hospital Colorado
Katie Larson Ode - Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA, USA
Andrea Granados - Department of Pediatrics, Washington University School of Medicine in St. Louis, MO, USA
Amir Moheet - University of Minnesota
Antoinette Moran - University of Minnesota
Shihab Hameed - University of New South Wales, Australia
Resource Type: Journal article
Publication Details: Journal of cystic fibrosis, Vol.18, pp.S25-S31
DOI: 10.1016/j.jcf.2019.08.025
PMID: 31679725
NLM abbreviation: J Cyst Fibros
ISSN: 1569-1993
eISSN: 1873-5010
Publisher: Elsevier B.V
Grant note: DOI: 10.13039/100000897, name: Cystic Fibrosis Foundation, award: CHAN16A0; name: Insulet and Dexcom; name: Washington University Institute of Clinical & Translational Sciences; DOI: 10.13039/100007930, name: ICTS; name: KL2 Career Development Awards Program, award: KL2TR002346-02; name: National Health and Medical Research Council of Australia; name: Australasian Cystic Fibrosis Research Trust; name: Regional Diabetes Support Scheme; name: Sydney Children's Hospital Foundation; DOI: 10.13039/100004319, name: Pfizer; DOI: 10.13039/501100004191, name: Novo Nordisk; DOI: 10.13039/100004374, name: Medtronic; DOI: 10.13039/100014386, name: Abbott Diagnostics; DOI: 10.13039/100000897, name: Cystic Fibrosis Foundation; name: EnVision: Emerging Leaders in CF Endocrinology Program
Language: English
Date published: 10/2019
Academic Unit: Endocrinology and Diabetes; Stead Family Department of Pediatrics
Record Identifier: 9984354510702771

Metrics

14 Record Views

37 Times Cited - Web of Science